These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Neonatal complications after the administration of indomethacin for preterm labor. Norton ME; Merrill J; Cooper BA; Kuller JA; Clyman RI N Engl J Med; 1993 Nov; 329(22):1602-7. PubMed ID: 8232428 [TBL] [Abstract][Full Text] [Related]
4. Effects of antenatal indomethacin on ductus arteriosus early closure and on adverse outcomes in preterm neonates. Doni D; Paterlini G; Locatelli A; Arnoldi S; Magri MC; Bernasconi D; Valsecchi MG; Tagliabue PE J Matern Fetal Neonatal Med; 2020 Feb; 33(4):645-650. PubMed ID: 29986620 [No Abstract] [Full Text] [Related]
5. Outcome of very low birth weight infants exposed to antenatal indomethacin for tocolysis. Doyle NM; Gardner MO; Wells L; Qualls C; Papile LA J Perinatol; 2005 May; 25(5):336-40. PubMed ID: 15861198 [TBL] [Abstract][Full Text] [Related]
6. Recent indomethacin tocolysis is not associated with neonatal complications in preterm infants. Vermillion ST; Newman RB Am J Obstet Gynecol; 1999 Nov; 181(5 Pt 1):1083-6. PubMed ID: 10561622 [TBL] [Abstract][Full Text] [Related]
7. Re: The debate regarding the risks of tocolytic agents. Humphrey M; King G Aust N Z J Obstet Gynaecol; 1998 Aug; 38(3):357-8. PubMed ID: 9761179 [No Abstract] [Full Text] [Related]
8. Antenatal indomethacin tocolysis is associated with an increased need for surgical ligation of patent ductus arteriosus in preterm infants. Soraisham AS; Dalgleish S; Singhal N J Obstet Gynaecol Can; 2010 May; 32(5):435-442. PubMed ID: 20500951 [TBL] [Abstract][Full Text] [Related]
9. The relationship between antenatal indomethacin as a tocolytic drug and neonatal outcomes: a retrospective cohort study. Rovers JFJ; Thomissen IJC; Janssen LCE; Lingius S; Wieland BV; Dieleman JP; Niemarkt HJ; van Runnard Heimel PJ J Matern Fetal Neonatal Med; 2021 Sep; 34(18):2945-2951. PubMed ID: 31597542 [TBL] [Abstract][Full Text] [Related]
10. Perinatal indomethacin treatment and neonatal complications in preterm infants. Ojala R; Ikonen S; Tammela O Eur J Pediatr; 2000 Mar; 159(3):153-5. PubMed ID: 10664225 [TBL] [Abstract][Full Text] [Related]
11. Metaanalysis of the effect of antenatal indomethacin on neonatal outcomes. Amin SB; Sinkin RA; Glantz JC Am J Obstet Gynecol; 2007 Nov; 197(5):486.e1-10. PubMed ID: 17980183 [TBL] [Abstract][Full Text] [Related]
18. Umbilical artery pH may be a possible confounder for neonatal adverse outcomes in preterm infants exposed to antenatal magnesium. Shimada E; Ogawa M; Matsuda Y; Mitani M; Matsui H J Matern Fetal Neonatal Med; 2013 Feb; 26(3):270-4. PubMed ID: 23020646 [TBL] [Abstract][Full Text] [Related]
19. Antenatal magnesium sulfate and the postnatal response of the ductus arteriosus to indomethacin in extremely preterm neonates. Katayama Y; Minami H; Enomoto M; Takano T; Hayashi S; Lee YK J Perinatol; 2011 Jan; 31(1):21-4. PubMed ID: 20505743 [TBL] [Abstract][Full Text] [Related]
20. Antenatal exposure to indomethacin increases the risk of severe intraventricular hemorrhage, necrotizing enterocolitis, and periventricular leukomalacia: a systematic review with metaanalysis. Hammers AL; Sanchez-Ramos L; Kaunitz AM Am J Obstet Gynecol; 2015 Apr; 212(4):505.e1-13. PubMed ID: 25448524 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]